Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1.
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1.
复制标题
DOI:
10.1016/0006-291x(84)90475-3
复制
发表时间:
1984-07
影响因子:
3.1
通讯作者:
N. Ling;A. Baird;W. Wehrenberg;N. Ueno;T. Munegumi;T. Chiang;M. Regno;P. Brazeau
中科院分区:
文献类型:
--
作者:
N. Ling;A. Baird;W. Wehrenberg;N. Ueno;T. Munegumi;T. Chiang;M. Regno;P. Brazeau
Eight position-1 analogs of the 40-amino acid fragment and two position-1 analogs of human growth hormone-releasing factor were synthesized by solid phase methodology and their capacity to release growth hormone was determined using rat anterior pituitary cells in monolayer culture. Relative to hGRF(1–40)OH, which was arbitrarily assigned a potency value of 1, [D-Tyr1]hGRF(1–40)OH, [Phe1]hGRF(1–40)OH, [Trp1]hGRF(1–40)OH, [His1]hGRF(1–40)OH, [Ala1]hGRF(1–40)OH, [(N-Ac)Tyr1]hGRF(1–40)OH, Arg0-hGRF(1–40)OH and Ala0-hGRF(1–40)OH have potencies of 0.022, 0.038, 0.003, 0.351, 0.010, 0.032, 0.002 and 0.007 respectively. Relative to hGRF(1–44)NH2= 1, [(3-Me)His1]hGRF(1–44)NH2and [[O-Me)Tyr1]hGRF(1–44)NH2have potiencies of 0.132 and 0.001 respectively. These results demonstrate the prerequisite for an aromatic residue at position-1 for potent biological activity and also suggest that the capacity for hydrogen bond formation with the first residue is required for full receptor-ligand interaction.